Paradigm Biopharmaceuticals Ltd. (AU:PAR) has released an update.
Paradigm Biopharmaceuticals Ltd. reported a decline in revenue by 24.02% and an increased net loss of 12.99% from the previous year in their preliminary final report for the fiscal year ending June 30, 2024. No dividends were issued, and the company’s basic earnings per share also saw a slight improvement from a loss of (20.78) cents to (20.00) cents. The company’s net tangible assets per share decreased significantly from 18.00 cents to 5.95 cents.
For further insights into AU:PAR stock, check out TipRanks’ Stock Analysis page.
